Abstract
INTRODUCTION: The problem of treatment of patients with chronic lower limb ischemia (CLLI) remains extremely important to date. This is first of all due to increase in the number of patients with chronic obliterating diseases of peripheral arteries, which hold one of the leading positions in the structure of morbidity and disability of the population over 60 years. The progression of the disease with development of critical CLLI leads to amputation of the limb within five years in a third of patients. The first line therapy for CLLI is endovascular interventions both stand-alone and with use of hybrid approach, especially in patients with critical CLLI. In many cases of multi-level, especially multifocal lesions of arterial vessels, the choice of revascularization tactics is not yet completely defined.
CONCLUSION: In recent years, there has been a trend of using endovascular revascularization technologies in continued stenosis and occlusions of the lower limb arteries. However, there is an essential need to study their long-term results, as well as to clarify the indications for stenting in critical CLLI.
Reference49 articles.
1. Global vascular guidelines on the management of chronic limb-threatening ischemia
2. Natsional’nyye rekomendatsii po diagnostike i lecheniyu zabolevaniy arteriy nizhnikh konechnostey. Moscow; 2019. (In Russ).
3. Pokrovskiy AV, Golovyuk AL. Sostoyaniye sosudistoy khirurgii v Rossiyskoy Federatsii v 2018 godu. Angiology and Vascular Surgery. 2019;25(2S):2–48. (In Russ).
4. Gaibov AD, Kalmykov EL, Kamolov AN. Thrombosis of femoral vein stump after lower limb amputation. Cardiology and Cardiovascular Surgery. 2011;4(5):71–5. (In Russ).
5. Editor's Choice – 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)